THE PRIMARY EXEMPT PURPOSE OF THE EICOSANOID RESEARCH FOUNDATION IS TO PROVIDE A FORUM FOR THE DISSEMINATION OF THE LATEST SCIENTIFIC INFORMATION ON BIOACTIVE LIPIDS IN HEALTH AND DISEASE AS IT RELATES TO CANCER, INFLAMATION AND INFLAMATION INDUCED DISEASES SUCH AS CARDIOVASCULAR, DIABETES, PSORIASIS AND ALZHEIMER'S. THIS PURPOSE IS ACCOMPLISHED THROUGH THE ORGANIZATION'S BIENNIAL CONFERENCE. THE EICOSANOID RESEARCH FOUNDATION SPONSORS BIENNIAL CONFERENCES HIGHLIGHTING DATA AT THE CUTTING EDGE OF MEDICAL SCIENCE. DURING THESE CONFERENCES NEW DRUGS AND MEDICATIONS ARE DISCUSSED, DATA ON CLINICAL TRIALS IS EXAMINED AND SCIENTISTS FROM ALL OVER THE WORLD INTERACT TO ENHANCE THEIR COLLABORATIVE RESEARCH EFFORTS. THE GOAL OF THIS MEETING SERIES IS TO PROMOTE THE EXCHANGE OF INFORMATION AND IDEAS AMONG INTERNATIONAL SCIENTISTS OF DIVERSE BACKGROUNDS. THE MAIN PURPOSE OF THE EICOSANOID RESEARCH FOUNDATION IS TO RAISE FUNDS TO SPONSOR THE INTERNATIONAL CONFERENCE ON BIOACTIVE LIPIDS IN CANCER,
Reported officers (all unpaid)
No paid executives reported in 2023. EICOSANOID RESEARCH FOUNDATION reported 6 unpaid officers and board members on its 990.
Compare any role, sector, or revenue band
Build your own benchmark from millions of reported positions.